METHYL 3,4-DIHYDRO-4-OXO-2H-1,2-BENZOTHIAZINE-3-CARBOXYLATE 1,1-DIOXIDE
UNII GHS4QA5XWR
Substance Identification & Data
This profile provides standardized clinical and technical data for Methyl 3,4-dihydro-4-oxo-2h-1,2-benzothiazine-3-carboxylate 1,1-dioxide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GHS4QA5XWR.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 29209-29-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C10H9NO5S HJAKVQDJSUIRPK-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Methyl 3,4-dihydro-4-oxo-2h-1,2-benzothiazine-3-carboxylate 1,1-dioxide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.